Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Neurobiol Dis ; 36(1): 223-31, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19635562

RESUMEN

Pyruvate, a key intermediate in glucose metabolism, was explored as a potential treatment in models of experimental stroke and inflammation. Pyruvate was administered to rodents after the onset of middle cerebral artery occlusion (MCAO). Since the extent of inflammation is often proportional to the size of the infarct, we also studied a group of animals given lipopolysaccharide (LPS) to cause brain inflammation without cell death. Following MCAO, pyruvate did not affect physiological parameters but significantly reduced infarct volume, improved behavioral tests and reduced numbers of neutrophils, microglial and NFkappaB activation. Animals given LPS showed increased microglial and NFkappaB activation which was almost completely abolished by pyruvate. Lactate, a major metabolite of pyruvate, was increased after pyruvate administration. However, administration of lactate itself did not have any anti-inflammatory effects. Pyruvate protects against ischemia possibly by blocking inflammation, but lactate itself does not appear to explain pyruvate's anti-inflammatory properties.


Asunto(s)
Infarto de la Arteria Cerebral Media/patología , Enfermedades del Sistema Nervioso/prevención & control , Ácido Pirúvico/metabolismo , Animales , Peso Corporal/efectos de los fármacos , Recuento de Células/métodos , Modelos Animales de Enfermedad , Ectodisplasinas/metabolismo , Encefalitis/sangre , Encefalitis/inducido químicamente , Encefalitis/tratamiento farmacológico , Encefalitis/patología , Infarto de la Arteria Cerebral Media/complicaciones , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Ácido Láctico/sangre , Lipopolisacáridos/farmacología , Masculino , Metaloproteinasa 9 de la Matriz/metabolismo , Microglía/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Enfermedades del Sistema Nervioso/etiología , Infiltración Neutrófila/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/metabolismo , Desempeño Psicomotor/efectos de los fármacos , Desempeño Psicomotor/fisiología , Ácido Pirúvico/sangre , Ácido Pirúvico/farmacología , Ratas , Ratas Sprague-Dawley , Sales de Tetrazolio , Quinasa de Factor Nuclear kappa B
2.
Ann Neurol ; 64(6): 654-63, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19107988

RESUMEN

OBJECTIVE: Hyperglycemia has been recognized for decades to be an exacerbating factor in ischemic stroke, but the mechanism of this effect remains unresolved. Here, we evaluated superoxide production by neuronal nicotinamide adenine dinucleotide phosphate (NADPH) oxidase as a possible link between glucose metabolism and neuronal death in ischemia-reperfusion. METHODS: Superoxide production was measured by the ethidium method in cultured neurons treated with oxygen-glucose deprivation and in mice treated with forebrain ischemia-reperfusion. The role of NADPH oxidase was examined using genetic disruption of its p47(phox) subunit and with the pharmacological inhibitor apocynin. RESULTS: In neuron cultures, postischemic superoxide production and cell death were completely prevented by removing glucose from the medium, by inactivating NADPH oxidase, or by inhibiting the hexose monophosphate shunt that generates NADPH from glucose. In murine stroke, neuronal superoxide production and death were decreased by the glucose antimetabolite 2-deoxyglucose and increased by high blood glucose concentrations. Inactivating NADPH oxidase with either apocynin or deletion of the p47(phox) subunit blocked neuronal superoxide production and negated the deleterious effects of hyperglycemia. INTERPRETATION: These findings identify glucose as the requisite electron donor for reperfusion-induced neuronal superoxide production and establish a previously unrecognized mechanism by which hyperglycemia can exacerbate ischemic brain injury.


Asunto(s)
Glucosa/fisiología , Neuronas/metabolismo , Accidente Cerebrovascular/metabolismo , Superóxidos/metabolismo , Animales , Muerte Celular/fisiología , Células Cultivadas , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Neuronas/enzimología , Neuronas/patología , Accidente Cerebrovascular/enzimología , Accidente Cerebrovascular/patología
3.
Mol Cell Neurosci ; 34(1): 40-7, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17101276

RESUMEN

Hypoxia-inducible factor 1 alpha (HIF-1alpha) is a transcription factor that was suggested in vitro to promote cell death by modulation of proapoptotic genes. In this report, we tested the hypothesis of an in vivo proapoptotic role of HIF-1alpha after an ischemic insult. For this purpose, HIF-1alpha and procaspase-3 mRNA and protein expressions were examined in rat brain subjected to 12- and 24-h permanent focal ischemia and the presence of an HIF-1 binding activity to the caspase-3 gene promoter was explored. The results showed that HIF-1alpha and procaspase-3 expressions increased with a similar pattern in response to ischemia. In addition, caspase-3 activation was observed in cells that express HIF-1alpha. Moreover, electrophoretic mobility assay revealed a specific HIF-1 binding activity to the caspase-3 gene promoter. Altogether the present data provide strong arguments for a causative relationship between HIF-1alpha and caspase-3 inductions through a functional binding activity to the caspase-3 gene promoter.


Asunto(s)
Caspasa 3/metabolismo , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Hipoxia-Isquemia Encefálica/metabolismo , Trombosis Intracraneal/metabolismo , Regiones Promotoras Genéticas/genética , Telencéfalo/metabolismo , Animales , Sitios de Unión/genética , Caspasa 3/genética , Modelos Animales de Enfermedad , Activación Enzimática/genética , Regulación Enzimológica de la Expresión Génica/genética , Subunidad alfa del Factor 1 Inducible por Hipoxia/genética , Hipoxia-Isquemia Encefálica/genética , Hipoxia-Isquemia Encefálica/fisiopatología , Trombosis Intracraneal/genética , Trombosis Intracraneal/fisiopatología , Masculino , Oxígeno/metabolismo , Unión Proteica/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Telencéfalo/fisiopatología
4.
Eur J Neurosci ; 22(5): 1045-56, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16176346

RESUMEN

Two different forms of cell death have been distinguished morphologically following cerebral ischaemia: necrotic and apoptotic cell death. The aim of this study was to investigate the contribution of apoptosis to ischaemic damage by carefully depicting the temporal and spatial neuronal death following focal ischaemia. For this purpose, rats were subjected to chemical photothrombosis, and histological and biochemical analyses were performed over a period of 24 h after the onset of ischaemia. In addition, the effects of the lipophilic antioxidant iron chelator 2,2'-dipyridyl (DP) were evaluated 24 h after photothrombosis when the lesion volume was maximal. Our results showed two separate waves of neuronal death. In the first wave, shrunken dark neurons were massively present as early as 2 h after photothrombosis in the infarct core. From this initial neuronal abnormal population, progressive and time-dependent changes of both necrotic and apoptotic cell death were observed, leading to ghost neurons and apoptotic bodies after 24 h. The extension of the lesion coincided with a second wave of cell death. Massive and rapid neuronal loss occurred at the infarct border, which appeared as a sharply demarcated pale region. Procaspase and poly(ADP-ribose) polymerase-1 (PARP-1) cleavages were also detected in the infarct core and surrounding damaged tissue. DP treatment markedly blocked the enlargement of the lesion, the infarct border being rescued from infarction. Furthermore, a large decrease of apoptotic bodies was associated with a significant drop of caspase and PARP-1 cleavages, suggesting that the protective effect of DP closely correlates with limitation of apoptosis expansion.


Asunto(s)
2,2'-Dipiridil/uso terapéutico , Apoptosis/fisiología , Isquemia Encefálica/patología , Quelantes/uso terapéutico , Animales , Western Blotting/métodos , Química Encefálica/fisiología , Química Encefálica/efectos de la radiación , Infarto Encefálico/patología , Infarto Encefálico/fisiopatología , Infarto Encefálico/prevención & control , Isquemia Encefálica/fisiopatología , Caspasa 3 , Caspasa 9 , Caspasas/metabolismo , Fragmentación del ADN/efectos de los fármacos , Fragmentación del ADN/fisiología , Modelos Animales de Enfermedad , Técnica del Anticuerpo Fluorescente/métodos , Lateralidad Funcional/efectos de los fármacos , Lateralidad Funcional/fisiología , Trombosis Intracraneal/patología , Trombosis Intracraneal/fisiopatología , Masculino , Poli(ADP-Ribosa) Polimerasa-1 , Poli(ADP-Ribosa) Polimerasas/metabolismo , Ratas , Ratas Wistar , Factores de Tiempo
5.
Eur J Neurosci ; 20(4): 937-46, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15305862

RESUMEN

To investigate the in vivo apoptotic machinery in oxygen deprived brain, we examined the expression of caspase-9 and caspase-3 in the hippocampus of Mongolian gerbils subjected to either transient hypoxia (4% O2 for 6 min) or forebrain ischemia (10 min bilateral carotid artery occlusion) followed by 8 h to 7 days of reoxygenation or blood recirculation. Apoptotic death was characterized by isolating hippocampal genomic DNA and analysing DNA fragmentation as well as histological studies including TUNEL assay and toluidine blue staining of brain sections. The results showed that both hypoxic and ischemic gerbil brains exhibited an increase in caspase-9 and caspase-3 gene expression. However, no cell damage was detectable following hypoxia, while marked DNA fragmentation and extensive cell death was observed following ischemia. Moreover, although hypoxia did not lead to cell death, both hypoxia and ischemia were associated with cleavage of procaspase-9 and procaspase-3 and increases in their activities as well as cleavage of poly(ADP-ribose) polymerase-1 (PARP-1), a major caspase-3 substrate. These results indicate that, in vivo, even late apoptotic events such as caspase activation and PARP-1 cleavage in hypoxic brains do not necessarily induce an irreversible commitment to apoptotic neuronal death.


Asunto(s)
Encéfalo/enzimología , Caspasas/metabolismo , Hipoxia Encefálica/enzimología , Neuronas/enzimología , Animales , Caspasa 3 , Caspasa 9 , Caspasas/genética , Muerte Celular/fisiología , Activación Enzimática/fisiología , Gerbillinae , Hipoxia Encefálica/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA